• TG Therapeutics average return on equity for 2024 was 23.29, a 114.14% decline from 2023.
• TG Therapeutics average return on equity for 2023 was -164.74, a 9.72% decline from 2022.
• TG Therapeutics average return on equity for 2022 was -150.15, a 62.13% increase from 2021.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.